@ARTICLE{
author={Dimopoulos Meletios Athanasios,...,Bila Jelena S,...,(broj koautora 21)},
year={2023},
title={Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3trial},
journal={LANCET HAEMATOLOGY},
volume={10},
number={10},
pages={E813-E824},
document_type={Article},
} 

@ARTICLE{
author={Dimopoulos Meletios Athanasios,...,Bila Jelena S,...,(broj koautora 23)},
year={2021},
title={Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial},
journal={LANCET ONCOLOGY},
volume={22},
number={6},
pages={801-812},
document_type={Article},
} 

@ARTICLE{
author={Beksac Meral,Seval Guldane Cengiz,Kanellias Nicholas,Coriu Daniel,Rosinol Laura,Ozet Gulsum,Goranova-Marinova Vesselina,Unal Ali,Bila Jelena S,Ozsan Hayri,Ivanaj Arben,Ibricevic-Balic Lejla,Kastritis Efstathios,Blade Joan,Dimopoulos Meletios Athanasios},
year={2020},
title={A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome},
journal={HAEMATOLOGICA},
volume={105},
number={1},
pages={201-208},
document_type={Article},
} 

@ARTICLE{
author={Beksac Meral,Seval Guldane Cengiz,Kanellias Nicholas,Coriu Daniel,Rosinol Laura,Ozet Gulsum,Goranova-Marinova Vesselina,Unal Ali,Bila Jelena S,Ozsan Hayri,Ivanaj Arben,Ibricevic-Balic Lejla,Kastritis Efstathios,Blade Joan,Dimopoulos Meletios Athanasios},
year={2020},
title={A real world multicenter retrospective study on extramedullary disease from Balkan Myeloma Study Group and Barcelona University: analysis of parameters that improve outcome},
journal={HAEMATOLOGICA},
volume={105},
number={1},
pages={201-208},
document_type={Article},
} 

